RESUMEN
The paper describes a clinical case of the rare tumor renal cell carcinoma associated with Xp11 translocations involving the TFE3 gene in a 53-year-old male patient. It provides the detailed characteristics of current diagnostic techniques.
Asunto(s)
Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice , Carcinoma de Células Renales , Neoplasias Renales , Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice/genética , Carcinoma de Células Renales/genética , Cromosomas Humanos X , Humanos , Inmunohistoquímica , Neoplasias Renales/genética , Masculino , Persona de Mediana Edad , Translocación GenéticaAsunto(s)
Antineoplásicos Alquilantes/efectos adversos , Médula Ósea/efectos de los fármacos , Ciclofosfamida/efectos adversos , Hematopoyesis/efectos de los fármacos , Células Madre Hematopoyéticas/efectos de los fármacos , Imidazoles/farmacología , Inmunosupresores/efectos adversos , Sustancias Protectoras/farmacología , Animales , Antineoplásicos Alquilantes/administración & dosificación , Apoptosis/efectos de los fármacos , Médula Ósea/patología , Caproatos , Diferenciación Celular/efectos de los fármacos , Ciclofosfamida/administración & dosificación , Femenino , Inmunosupresores/administración & dosificación , RatasRESUMEN
The aim of research has been the estimation of a proliferative potential as simultaneous detection of a proliferative cells number (Ki-67 index) and duration of mitosis (nucleolar argyrophilic protein expression--B23/nucleophosmin and C23/nucleolin) at patients with adrenocortical cancer. In according to lifetime of patients after operation 2 groups had been sorted out. The first one included patients surviving 56.12 months, the second one--9.25 months. We've found out that different aspects of tumor diagnosis as well distinction of benignant or malignant tumor growth, a malignant degree of tumors, a prognostic criteria of illness, survival of patients etc. must be characterized by total research both a proliferative cells fraction (Ki-67 index) and a rate of mitosis (expressions of B23/nucleophosmin and C23/nucleolin).
Asunto(s)
Neoplasias de la Corteza Suprarrenal , Antígenos de Neoplasias/biosíntesis , Regulación Neoplásica de la Expresión Génica , Proteínas de Neoplasias/biosíntesis , Neoplasias de la Corteza Suprarrenal/metabolismo , Neoplasias de la Corteza Suprarrenal/mortalidad , Neoplasias de la Corteza Suprarrenal/cirugía , Neoplasias de la Corteza Suprarrenal/ultraestructura , Supervivencia sin Enfermedad , Femenino , Humanos , Masculino , Mitosis , Tasa de SupervivenciaRESUMEN
The prognosis in papillary thyroid cancer (PTC) is usually good. Ten-year survival can be seen in 90-98% of patients. Immunohistochemical study (antigen K-67) ascertained that a female patient with PTC had a low number of proliferating cells, which is usually seen in the favorable course of the disease. However, in the presented case, PTC was highly aggressive and showed a significant invasive growth, provided regional and distant metastases, rapidly progressed and, despite the performed surgical treatment, the patient died due to disease progression 3 months after surgery. This discrepancy between the number of proliferating cells and the aggressive course of PTC should be explained by the high expression of argyrophilic nucleolar organizer region associated proteins nucleofozmin and nucleolin, detected by immunohistochemical study, which is known to cause an increase in the rate of a mitotic cycle rate and to promote intercellular adhesion and enhancement of invasive growth and metastatic spread. Various factors involved in the regulation of proliferation of cells and their capacity for invasion and metastasis should be studied to make the most objective estimation of the degree of malignancy of a tumor and its prognosis.
Asunto(s)
Antígenos Nucleares/biosíntesis , Regulación Neoplásica de la Expresión Génica , Mitosis , Carcinoma , Carcinoma Papilar , Femenino , Humanos , Antígeno Ki-67/biosíntesis , Persona de Mediana Edad , Invasividad Neoplásica , Metástasis de la Neoplasia , Pronóstico , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides/metabolismo , Neoplasias de la Tiroides/patologíaAsunto(s)
Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/metabolismo , Carcinoma/diagnóstico , Carcinoma/tratamiento farmacológico , Receptores de Somatostatina/metabolismo , Somatostatina/análogos & derivados , Somatostatina/metabolismo , Carcinoma/metabolismo , Carcinoma Neuroendocrino/diagnóstico , Carcinoma Neuroendocrino/tratamiento farmacológico , Regulación Neoplásica de la Expresión Génica , Humanos , Somatostatina/uso terapéuticoAsunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Médula Ósea/efectos de los fármacos , Hematínicos/uso terapéutico , Imidazoles/uso terapéutico , Neoplasias Ováricas/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Caproatos , Ciclofosfamida/efectos adversos , Desoxicitidina/efectos adversos , Desoxicitidina/análogos & derivados , Doxorrubicina/efectos adversos , Femenino , Humanos , Leucopenia/inducido químicamente , Leucopenia/tratamiento farmacológico , Persona de Mediana Edad , Neutropenia/inducido químicamente , Neutropenia/tratamiento farmacológico , Neoplasias Ováricas/patología , Resultado del Tratamiento , GemcitabinaRESUMEN
S u m m a ry. - The subject of the study was 20 cases of non-small-cell lung carcinomas, up to 3 cm in diameter, conventionally designed as minimal lung cancers removed in patients operated on at the N. N. Blokhin Cancer Research Centre, Russian Academy of Medical Sciences in 1986 to 2001. According to survival rates after surgery, the patients were divided into two groups: 1) those who died within the first two years; 2) those who were followed up for 3-5 years. Histological, histochemical, and immunohistochemical studies were performed. The expression of argyrophylic nucleolar organizer site proteins (Ag-NOS-proteins) that characterized the rate of cell proliferation (the duration of a cellular cycle) and the expression of Ki-67 antigen, which reflected the fraction of growth (the number of proliferating cells), were revealed in the tumor cells. Minimal lung cancers were found to be a heterogeneous group of neoplasms showing differences in both the rate of cell proliferation and the count of proliferating cells. The cell proliferation rate is a determinant of the clinical course of minimal lung cancers. Group 1 tumors characterized by the superexpression of Ag-NOS-proteins and, accordingly, the higher cell proliferation rate and the moderate count of proliferating cells had a poor prognosis even in the presence of Stage IA whereas Group 2 tumors with a large quantity of proliferating cells, but with the less rate of cell proliferation were characterized by a much better prognosis. The rate of cell proliferation (expression of Ag-NOS-proteins) and the count of proliferating cells (the expression of Ki-67 antigen) should be simultaneously studied to have more complete information on the proliferative potential of tumor cells and on the prediction of the course of neoplasms.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Regulación Neoplásica de la Expresión Génica , Antígeno Ki-67/biosíntesis , Neoplasias Pulmonares/metabolismo , Proteínas de Neoplasias/biosíntesis , Carcinoma de Pulmón de Células no Pequeñas/clasificación , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Pulmón de Células no Pequeñas/patología , Proliferación Celular , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Pulmonares/clasificación , Neoplasias Pulmonares/mortalidad , Neoplasias Pulmonares/patología , Masculino , Región Organizadora del Nucléolo/metabolismo , Región Organizadora del Nucléolo/patología , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Tasa de SupervivenciaAsunto(s)
Úlcera Duodenal/tratamiento farmacológico , Ácido Gástrico/metabolismo , Mucosa Gástrica/efectos de los fármacos , Sistemas Neurosecretores/efectos de los fármacos , Inhibidores de la Bomba de Protones/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Úlcera Duodenal/metabolismo , Úlcera Duodenal/patología , Estudios de Seguimiento , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Humanos , Sistemas Neurosecretores/metabolismo , Úlcera Gástrica/metabolismo , Úlcera Gástrica/patología , Factores de Tiempo , Resultado del TratamientoRESUMEN
Optical parameters of human cell nucleoli (HCT116 colorectal cancer cells) in depolymerization of microtubules and depletion of intracellular ATP pool were studied by coherent phase microscopy. These influences were associated with a rapid (recorded within the first minutes) reduction of the phase thickness of the nucleoli. These changes are similar to the nucleolar response to direct inhibitors of transcription. Hence, quantitative parameters of coherent phase microscopy describe common reaction of the nucleolus to stress; reduction of optical thickness of the nucleolus is a component of this reaction.
Asunto(s)
Nucléolo Celular/metabolismo , Microscopía de Contraste de Fase/métodos , Adenosina Trifosfato/metabolismo , Línea Celular Tumoral , Nucléolo Celular/ultraestructura , Humanos , Microscopía Electrónica de Transmisión , Microtúbulos/metabolismo , Microtúbulos/ultraestructuraRESUMEN
Changes in the antral gastric mucosa of patients with doudenal ulcer after a long-term administration of antisecretory agents were studied. The subjects were five patients with a different duration of the disease. The methods applied included light and electron microscopy of tissue samplings taken from the antral part of the stomach during the periods of exacerbation and remission. In addition to well-known morphological changes, cellular principalis not typical of antral gastric mucosa were found in one patient during exacerbation and remission periods.
Asunto(s)
Úlcera Duodenal/tratamiento farmacológico , Ácido Gástrico/metabolismo , Mucosa Gástrica/ultraestructura , Antagonistas de los Receptores H2 de la Histamina/uso terapéutico , Antro Pilórico/patología , Adolescente , Anciano , Biopsia , Úlcera Duodenal/metabolismo , Úlcera Duodenal/patología , Endoscopía Gastrointestinal , Femenino , Estudios de Seguimiento , Mucosa Gástrica/efectos de los fármacos , Humanos , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Antro Pilórico/efectos de los fármacos , Antro Pilórico/metabolismo , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
The paper reviews the literature on the role of the above proteins in the mechanisms of cell cycle regulation and presents data on changes in protein expression in dynamics of cell cycle. The significance of studies dealing with the expression of these proteins, which, along with the assessment of a cell population growth fraction, allow one to characterize the rate of cell proliferation that under malignant growth is the determinant of cell proliferative status, which has a great impact on tumor progression, is discussed. The data on the diagnostic value of these proteins as an independent predictor for a broad spectrum of tumors are considered.
Asunto(s)
Antígenos Nucleares/análisis , Antígenos Nucleares/metabolismo , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/metabolismo , Neoplasias/diagnóstico , Proteínas Nucleares/análisis , Proteínas Nucleares/metabolismo , Proliferación Celular , Humanos , PronósticoAsunto(s)
Investigación Biomédica/historia , Instituciones Oncológicas/historia , Oncología Médica/historia , Academias e Institutos/historia , Investigación Biomédica/educación , Investigación Biomédica/organización & administración , Instituciones Oncológicas/organización & administración , Docentes Médicos/historia , Georgia (República) , Historia del Siglo XX , Humanos , Oncología Médica/educación , Oncología Médica/organización & administraciónAsunto(s)
Antioxidantes/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Melatonina/uso terapéutico , Adolescente , Adulto , Antiulcerosos/uso terapéutico , Úlcera Duodenal/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/uso terapéutico , Índice de Severidad de la EnfermedadRESUMEN
The purpose of the study was to evaluate the clinical effectiveness of melatonin (melaxen, Unipharm, USA), and its influence on the ultrastructural and histological features on the colon mucosa (CM) in patients with irritable bowel syndrome (IBS) corresponding to Rome criteria II. Twenty-one patients with IBS were examined before and after the end of the therapy (one month upon the beginning of treatment). All the patients had non-specific morphological changes in the CM, which were more pronounced during exacerbation and less significant during remission. The study showed that in terms of stool normalization and sleep improvement in IBS patients the combination of basic therapy and melaxen was more effective than either the combination of basic therapy and psychotropic drugs or basic therapy alone. Basic therapy plus melaxen is comparable in its effects to basic therapy plus psychotropic drugs in terms of coping with pain syndrome and dyspeptic syndrome in IBS patients, the normalization of their mental status and life quality improvement. The treatment of IBS with melaxen proved to be more effective than other therapies, which was proved by histological and electron microscopic studies of the CM.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Síndrome del Colon Irritable/tratamiento farmacológico , Síndrome del Colon Irritable/patología , Melatonina/uso terapéutico , Sigmoidoscopía/métodos , Adolescente , Adulto , Biopsia , Colon/efectos de los fármacos , Colon/patología , Femenino , Estudios de Seguimiento , Humanos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/ultraestructura , Masculino , Persona de Mediana Edad , Calidad de Vida , Resultado del TratamientoRESUMEN
Primary liver tumors, including 7 low-grade hepatocellular carcinomas (HC), 12 average-grade HC (including 2 mixed tumors and 2 cholangiocellular carcinomas (ChC)), obtained from 23 patients, were histologically, immunohistochemically, and electron microscopically. Certain markers were immunohistochemically studied to identify HC and ChC and differentiate liver carcinoma from metastatic tumors of the same organ.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/ultraestructura , Diagnóstico Diferencial , Femenino , Humanos , Inmunohistoquímica/métodos , Neoplasias Hepáticas/diagnóstico , Masculino , Microscopía Electrónica de Transmisión/métodosRESUMEN
The use of coherent phase microscopy for online quantitative registration of nucleolar reaction to transcription inhibition is validated. Reduction of phase thickness of the nucleoli was detected during the first minutes of the experiment; 30 min after addition of the drug rarefaction zones predominated and areas of condensation were seen. These changes reflect the dynamics of disorders in the nucleolar ultrastructure during transcription inhibition.
Asunto(s)
Nucléolo Celular/patología , Dactinomicina/farmacología , Transcripción Genética/efectos de los fármacos , Células 3T3 , Animales , Neoplasias de la Mama , Línea Celular Tumoral , Nucléolo Celular/efectos de los fármacos , Nucléolo Celular/ultraestructura , Femenino , Humanos , Cinética , Ratones , Neoplasias del RectoRESUMEN
Oncocytic adenomas have primarily follicular structure; trabeculas, solid areas, necrosis are rare. They may possess malignant potential as their malignant transformation occurs in 35% cases against 5% in adenomas of follicular cells. Oncocytic follicular carcinomas can be hardly distinguished from oncocytic adenomas. Tumors larger than 4-5 cm in diameter are considered to be malignant. Main difference with adenomas is invasion into the capsule surrounding thyroid or into the vessels. They can be well or poorly differentiated or anaplastic. Oncocytic papillary carcinoma and oncocytic medullary carcinoma are rare. The clinical course of oncocytic tumors is more aggressive than that of tumors from follicular cells. Of key importance in differential diagnosis is electron microscopy (EM) and immunohistochemistry with antimitochondrial antibodies. EM may be also useful in determination of the degree of oncocytic tumors maturation.
Asunto(s)
Adenoma Oxifílico/patología , Mitocondrias/patología , Glándula Tiroides/patología , Nódulo Tiroideo/patología , Adenoma Oxifílico/diagnóstico , Adenoma Oxifílico/metabolismo , Anciano , Carcinoma Medular/diagnóstico , Carcinoma Medular/metabolismo , Carcinoma Medular/patología , Carcinoma Papilar Folicular/diagnóstico , Carcinoma Papilar Folicular/metabolismo , Carcinoma Papilar Folicular/patología , Diferenciación Celular , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Mitocondrias/metabolismo , Glándula Tiroides/metabolismo , Nódulo Tiroideo/diagnóstico , Nódulo Tiroideo/metabolismoRESUMEN
We propose a system for detection of overproduction of protein kinase MAK-V/Hunk in tumours. MAK-V/ Hunk overproduction is observed in about 50% breast carcinomas. Positive staining is obseved in tumour cells only and has mainly cytoplasmic characteristics. Increased production of MAK-V/Hunk does not correlate with histological type of carcinoma, metastasizing, steroid receptor status (estrogen and progesterone), proliferative activity. Tumours positive for MAK-V/ Hunk were more frequently observed in c-erbB2-positive (3+) tumours than in c-erbB2-negative ones. Overproduction of MAK-V/Hunk in human breast cancer may be used fore more precise molecular typing of this tumour, in particular in case of c-erbB2-positive tumors, however, diagnostic-prognostic value of this new molecular marker needs further studies.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/enzimología , Proteínas Quinasas/metabolismo , Adulto , Anciano , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/patología , Proliferación Celular , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Metástasis de la Neoplasia , Pronóstico , Receptor ErbB-2/metabolismo , Receptores de Estrógenos/metabolismoRESUMEN
Expression of argyrophilic proteins of nucleolar organizers regions (Ag-NOR-proteins) was studied in tumor cells from 17 patients with a classic variant of anaplastic large-cell lymphoma (ALCL) and 22 patients with Hodgkin's lymphoma (HL). Eight cases of p80+ and nine cases of p80-ALCL were studied. HL was represented by 13 cases with lymphoid depletion by a reticular type and 9 cases with nodular sclerosis with a syncytial growth. Ag-NOR-proteins were identified using histochemical method with silver nitrate. The expression of Ag-NOR-proteins in tumor cells of ALCL and HL appeared intensive, being highest in ALCL cells, in p80+ cells of ALCL there was superexpression. The differences in expression of Ag-NOR-proteins point to different proliferative activity and growth of the above variants of ALCL and HL. The test for Ag-NOR-proteins expression can be recommended as an additional tool in differential diagnosis, determination of malignancy grade, assesssment of prognosis and sensitivity to chemotherapy.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Enfermedad de Hodgkin/metabolismo , Linfoma de Células B Grandes Difuso/metabolismo , Región Organizadora del Nucléolo/metabolismo , Antígenos CD/metabolismo , Antígenos Nucleares/biosíntesis , División Celular , Diagnóstico Diferencial , Enfermedad de Hodgkin/patología , Humanos , Linfoma de Células B Grandes Difuso/patología , Proteínas Nucleares/biosíntesis , Región Organizadora del Nucléolo/patología , Proteínas Tirosina Quinasas/metabolismoRESUMEN
Vilon stimulated and Epithalon suppressed the expression of argyrophilic proteins in nucleolar organizer regions of thymocytes and epithelial cells, stimulating or reducing, respectively, the formation, assembly, and transport of ribosomes into the cytoplasm and thus determining the intensity of protein synthesis in these cells. A direct mitogenic effect of Vilon was also revealed: this peptide promoted thymocyte transformation into proliferating blast cells.